Unison Pharmaceuticals Pvt. Ltd.
Tanuj Khandelwal is a Regulatory Affairs Executive at Cadila Pharmaceuticals Limited, with experience in CMC and Post Approval since April 2021. Previously, Tanuj worked at Medreich Limited, focusing on CMC in a Regulatory Affairs role from June 2019 to April 2021. Tanuj began a career in regulatory affairs as an intern at Hetero Labs Limited from July 2018 to December 2018. Tanuj holds a Master of Pharmacy in Pharmaceutical Regulatory Affairs from JSS Academy of Higher Education and Research, completed in 2019, and a Bachelor of Pharmacy from Careers in Pharmacy, awarded in 2017. Early education includes attendance at Nobel School Falna and Vivek Senior Secondary School Bali.
This person is not in the org chart
This person is not in any teams
Unison Pharmaceuticals Pvt. Ltd.
2 followers
With almost four decades of medical service to the society, Unison Pharmaceuticals is an emerging global pharmaceutical company with strong identity in Indian market (Gujarat) and started spreading the wings in regulated and semi-regulated markets. Our vision of becoming a globally renowned company is supported by dedicated team of R&D scientists, pharmacists and state-of-an-art manufacturing facilities equipped with latest technologies. Our philosophy is to provide world class quality medicines at most affordable price to ensure the best healthcare possible. With our core competence in chronic segments; Anti-Hypertensives, Anti-Diabetics and Lipid-Lowering drugs, we have more than 165 products in the basket with presence in different therapeutic segments like; Anti-hypertensives, Anti-Diabetics, Lipid-lowering, Anti-Infective, Anti-biotics, Respiratory management, Hematinics, Anti-Allergics, Steroids, Psychotropics, Calcium and Vitamin Supplements and others.